More treatment arms can help separate ingredients, but only if the relevant contrasts are actually reported and interpreted correctly. Primary study
What was studied
The study randomized 133 participants among magnesium, L-carnitine, combined supplementation and control groups alongside routine care. Migraine indicators improved across all groups. The abstract reported an overall group difference for frequency and an adjusted finding for magnesium; it does not justify assigning every favorable result specifically to carnitine. Primary report
Our appraisal: an overall group test does not identify the winning ingredient
An omnibus test can show that at least some group means differ without establishing which pair differs. To claim a carnitine effect, the relevant carnitine-versus-control contrast must be examined. To claim that the combination adds value beyond magnesium, that separate contrast is needed too.
Improvement in every group highlights why baseline-to-follow-up change alone is insufficient. Routine treatment, regression toward typical symptom levels and other time-related influences can contribute. Randomization supports the between-group comparison, not automatic attribution of all improvement in an active arm to its supplement.
The statistical model also matters. Adjustment can help account for measured differences, but its terms, assumptions and prespecification need inspection. A favorable adjusted magnesium result cannot be treated as a carnitine result merely because both appear in the title.
This paper is useful for an ingredient-attribution discussion and for mapping early migraine research. It does not establish synergy, equivalent efficacy among supplements or superiority to standard treatment. A final evidence synthesis should compare the exact carnitine form, population and comparator with other trials rather than treating all metabolic supplements as one intervention.
Frequently asked questions
Were there separate ingredient arms?
Yes.
Did only the active groups improve over time?
No; improvement was reported across groups.
Does an omnibus P value identify every pairwise difference?
No.
Was routine treatment part of the context?
Yes.
Can a magnesium finding be credited to carnitine?
No.
Does a combination arm alone prove synergy?
No.
What needs full-report review?
Direct contrasts, modeling choices and outcome hierarchy.